Plasticity of human tumor populations could account for the reason why many tumorigenic human cell lines lose this feature when grown in culture. 
An acceptable system for evaluating malignant potential is to use a surrogate host such as a nude mouse to measure tumorigenicity (1, 2) . Normal human cells are more resistant than rodent cells to tumorigenic conversion by chemical carcinogens and oncogenes. Even though tumors from human cells have been obtained in nude mice by injection of chemically transformed human fibroblasts (3, 4) , this approach has not always been successful (5) . Transfection of primary or early-passage human diploid fibroblasts with oncogenes has resulted in anchorage-independent colony formation (6-8) and foci formation (7, 8) , but tumorigenicity has not been observed. Yokum et al. (9) have reported that transfection of human bronchial epithelial cells with v-Ha-ras (viral Harvey ras sarcoma oncogene) produced transformed cells that became tumorigenic after 100-120 population doublings.
Unlike the primary or early-passage human cells, cell lines with infinite life span have been more frequently transformed to tumorigenic phenotypes by oncogenes or chemicals. For example, an immortalized human skin fibroblast cell line has been converted to a malignant phenotype by transfection with the human homologue, HRAS, of the v-Ha-ras oncogene (10) . The tumorigenic conversion of an immortalized human bronchial epithelial cell line has been achieved by infecting v-Ha-ras-containing retrovirus (11) or by transfecting with a plasmid containing the v-Ki-ras region from Kirsten murine sarcoma virus (12) . Boukamp et al. have reported that malignant transformation of keratinocyte cell lines by the v-Ha-ras oncogene (13) . N-Methyl-N'-nitro-N-nitrosoguanidine (MNNG) treatment of nontumorigenic osteosarcoma cell line (14) and T24 human bladder carcinoma cell line (15) has resulted in tumorigenic conversion of these cells.
The tional 5% (vol/vol) fetal bovine serum at 370C in a 4% C02-enriched air atmosphere for 4 hr (1, 19, 20) .
Anchorage-Independent Growth. Cells were evaluated for their ability to produce colonies in soft agar as described by Milo et al. (21) . Colonies containing 50 cells 2 60 gm in diameter were counted after 2 weeks.
MMS Treatment. Two million SCC-83-01-82 cells were seeded into several 100-mm diameter Petri dishes in 10 ml of growth medium. When these cells grew to a monolayer, MMS was added at 50,ug/ml, and the mixture was incubated for 24 hr at 370C in a 4% C02-enriched air atmosphere (1).
Tumorigenicity Assay. All lines were assayed for tumorigenicity. Three-to 4-week-old gnotobiotic nude mice were splenectomized and then injected subcutaneously into the subscapular area with ca. 1 x 107 cells suspended in minimal essential medium (2) .
In Situ Hybridization. DNA probes for HRAS, MYC, and the keratin gene were used to examine 8-Am frozen cross sections for the expression of these genes at the RNA level (1). The DNA probes were labeled by nick-translation (30) with biotinylated dUTP and were hybridized with the sections overnight in hybridization solution with 50% (vol/vol) formamide at 37°C (22) . The hybridization pattern was detected with horseradish peroxidase-conjugated avidin. The cells expressing the different messages were identified with diaminobenzidine*HCI and H202, counterstained with hematoxylin, and examined under x40 magnification (2) . RNA (Northern) Blot-Hybridization Analysis. Total cellular RNA was isolated by the guanidinium isothiocyanate/CsCl method (23) and then electrophoresed on a 1.2% agarose denaturing gel by the method of Maniatis et al. (24) . The gel was stained with ethidium bromide and visualized for equivalent loading of RNA among lanes by comparison of the intensities of the 28S and 18S RNA bands.
The transfer, prehybridization, hybridization, and wash steps were performed according to the instructions of the supplier of the nylon membranes (Schleicher & Schuell). The membranes were then exposed overnight to Kodak XAR-5 film at -70°C with an intensifying screen.
The DNA probes were radioactively labeled with [a-32P]dCTP (specific activity = 3000 Ci/mmol, ICN; 1 Ci = 37
GBq) by the random-primer method (Pharmacia) according to the manufacturer's instructions. pSVc-myc-1 was obtained from American Type Culture Collection, and the KRAS probe was purchased from Oncor, Gaithersburg, MD. Southern Blot Analysis. High molecular weight genomic DNA was isolated from various SCC cell lines and from SCC tumors produced in nude mice as described by Maniatis et al. (24) . Restriction digests of genomic DNA were carried out according to the instructions of the supplier of the restriction enzymes (Bethesda Research Laboratories). Southern transfers were also performed as described by Maniatis et al. (24) .
The BA85 nitrocellulose filters (Schleicher & Schuell) were baked for 2 hr at 80°C under vacuum and then prehybridized, hybridized, and washed as described by Fu and Marzluf (25) . The filters were exposed to Kodak XAR-5 film at -70°C for 48 hr with an intensifying screen.
The DNA probes were radioactively labeled with [a-32P]dCTP (specific activity = 800 Ci/mmol; NEN) by nicktranslation (30 (Fig. 1 A and B) . When the level of MYC mRNA in the MMS-SCC-83-01-82 cells was compared with the level in mouse tumors derived from these cells, no MYC expression was detected in the tumors (Fig. 1C) . (26) describes the acquisition of mouse retroviral sequences by human cell lines passaged through nude mice and demonstrates that the detection of an 8.5-to 9.5-kilobase (kb) RNA transcript in these cell lines by the pSM3 probe is due to sequence homology between the pol regions of the Susan McDonough strain offeline sarcoma virus contained in pSM3 and of AKR murine leukemia virus (AKV). Our results demonstrate that these tumors did not acquire murine retrovirus sequences.
The expression of MYC and HRAS in the various nude mice tumors was also analyzed by in situ hybridization ( Table  2 ). Certain subpopulations of cells in a representative tumor derived from the MMS-treated human SCC-83-01-82 cell line demonstrated increased MYC and HRAS mRNA levels. These subpopulations contained both keratin mRNA and keratin proteins as detected by in situ hybridization and immunohistochemistry. However, the levels of HRAS and keratin mRNA decreased to undetectable amounts by in situ hybridization in the successively generated tumors. Detectable levels of MYC mRNA were still present in subpopulations of cells in a representative tumor derived from the SCC-83-01-82 CA cell line, but the MYC mRNA level began to decrease in tumors derived from SCC-83-01-82-CA1 and became undetectable in a SCC-83-01-82 CA2 cell line derived from a tumor. Sst 1 (14.5, 3.1, and 1.6 kb) , and Xba 1 (7.1 and 6.9 kb) fragments (Fig. 3) . Comparison of the MYC copy number detected in the EcoRI digests of the above DNA samples to that in normal human fibroblast DNA did not indicate any MYC amplification (Fig. 4) .
DISCUSSION
The tumorigenicity of immortal cell lines isolated from human malignancies cannot be consistently predicted. Cell lines have been isolated that have been initially tumorigenic but after prolonged propagation in cell culture have lost this tumorigenic capacity (15) . It has been shown that the capacity for tumorigenesis could be acquired in such cell lines after exposure to a carcinogen such as MNNG (14, 15) . The mechanism for these conversions was not the same in the different cell lines. In the present study, we have exposed a nontumorigenic SCC cell line to a very weak carcinogen, MMS, and converted the cell line to tumorigenicity.
The carcinogenic potential of MMS and MNNG is not equal. MMNG is an excellent carcinogen in human cells and can convert normal cells to transformed cells that exhibit anchorage-independent growth and cellular invasiveness (3) . MMS, while a methylating agent, is a very weak human carcinogen and has not been shown to be able to transform either normal human fibroblasts or normal human keratinocytes (unpublished data). The effects of MNNG in the tumorigenic conversion of immortalized cell lines vary, dependent on the cell line. In a nontumorigenic human osteosarcoma, the effects of MNNG have been associated with a gene rearrangement and onset of expression of the MET oncogene (27) . The tumorigenic conversion of T24 human bladder carcinoma cells by MNNG was not associated with new expression of MET or alteration in the levels of expression of the mutated HRAS, which the cells already contained (15) . Thus, there does not appear to be a consistent molecular A B
,F C Ult a mechanism associated with the activation of nontumorigenic cells by MNNG. In this study, we have examined the molecular changes associated with the tumorigenic conversion of SCC cells by MMS. The nontumorigenic SCC cells exhibited an altered growth pattern with an extended life-span and pleomorphic morphology. They also retained the capacity for growth in soft agar.
After treatment with MMS, the SCC cells did not demonstrate significant changes in the level of MYC, HRAS, or KRAS mRNAs. Furthermore, neither amplification or obvious rearrangement in specific regions of the MYC gene nor a mutation in the 12th codon of HRAS associated with transformation was present. However, this does not exclude a mutation in codon 61 of HRAS or mutations in either site of KRAS or NRAS. These MMS-exposed cells acquired the capacity for tumorigenesis and produced progressively growing tumors in nude mice hosts. Analysis of these tumors by in situ hybridization revealed increased HRAS and MYC expression in discrete subpopulations of tumor cells. However, this expression did not persist in subsequent cell lines or tumors.
Thus, there is the possiblity of a transient genetic response of oncogenes (28) . Even though these subsequent cell lines do not appear to have alterations in the MYC and HRAS genes, they are capable of a much more rapid development of tumors, which also do not contain such alterations. The generation of these various cell lines resulted in a further demonstration of the plasticity of the tumorigenic potential of cell lines derived from human malignancies.
Previously we have described the presence of different subpopulations in tumors that have different phenotypic characteristics and different biologic potentials (1) . The presence of cell populations that may remain plastic in their commitment to tumorigenesis may be directly related to the methods of identification. In other studies converting nontumorigenic cells to tumorigenicity, the in vitro-in vivo transition appears to be a critical point (14, 15) the in vivo environment results in an alteration in the cells that does not affect immortalization but changes the biologic potential of the cells in vivo. The transition to the in vitro situation might increase the expression of genetic elements that reverse the tumorigenicity of the cell line. Interestingly, the studies described to date to convert nontumorigenic cells in culture to tumorigenicity have used either MNNG or MMS, which are both alkylating agents. These two chemicals both add methyl groups to DNA, and the mutational activity of these chemicals is associated with the development of the DNA adducts (29) . If in the present case and in previous studies a suppressor gene was methylated and mutated by the effects of chemical exposure and thus inhibited, the tumorigenic capacity could be fully expressed by the cells. In this manner, the cycle could be continued as has been shown, and the cells would maintain tumorigenicity as long as they continue in vivo-in vivo passages. Thus, the development of in vitro cell lines would be associated with changes in gene expression that affect tumorigenicity but not immortalization. The effect of the chemical mutagen would then be needed for the cells to reacquire tumorigenicity.
